The Largest Registry on the ACURATE neo Valve

Transcatheter aortic valve replacement (TAVR) using the ACURATE neo device depends, largely, on correct patient selection and appropriate oversizing. The individual anatomy of each patient, namely periannular and aortic root calcification, must be taken into account.

The ACURATE neo valve (Symetis/Boston, Ecublens, Switzerland) is a new-generation self-expanding valve characterized by a stent design shaped as an X and a unique release mechanism. This work analyzed technical and anatomical predictors for proper implantation of this device.

A total of 500 patients who underwent TAVR with the ACURATE neo valve were stratified according to landing zone calcification level (mild, moderate, or severe). Predictors of moderate or greater paravalvular leak and need for permanent pacemaker implantation were assessed.


Read also: Renal Impairment: How Does It Affect Angioplasty and Surgery?


Post-procedural moderate or greater paravalvular leak was more frequent with increasing device landing zone calcification (mild, 0.8% vs. moderate, 5.0% vs. severe, 13.0%; p < 0.001), while the need for permanent pacemaker implantation was independent of calcification.

The greater the periannular calcification (p < 0.001), the lesser the oversizing (p = 0.014), the higher the presence of annular plaque protrusions (p = 0.025), the greater the movement of the release system after full valve deployment (p = 0.02), and the higher the sinotubular junction height (p = 0.04). There was a higher rate of paravalvular insufficiency.


Read also: DEFENSE-PFO: High Risk PFO Closure Reduces Combined Events and Stroke Risk.


As regards predictors of permanent pacemaker implantation, there were no surprises compared with other studies or devices: pre-existing right bundle branch block and more oversizing.

Conclusion

Procedural success using the ACURATE neo device depends on appropriate oversizing and consideration of individual anatomy, mainly periannular and aortic root calcium distribution. To sum up, success depends on correct patient selection.

Original title: The ACURATE Neo Transcatheter Heart Valve. A Comprehensive Analysis of Predictors of Procedural Outcome.

Reference: Won-Keun Kim et al. J Am Coll Cardiol Intv 2018. Online before print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Su opinión nos interesa. Puede dejar su comentario, reflexión, pregunta o lo que desee aquí abajo. Será más que bienvenido.

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...